Our results show that combined high levels of IL-6 and IL-10 in patients with pneumonia can have a significant impact on clinical practice by differentiating between COVID-19 and non-COVID-19 pneumonia. This evidence concerns the gene IL10 and susceptibility to pneumonia measurement.